|
May 5
|
Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
|
|
May 4
|
Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
|
May 3
|
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
|
|
May 3
|
Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
|
|
May 2
|
Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
|
|
May 2
|
Puma Biotechnology Reports First Quarter Financial Results
|
|
Apr 29
|
Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?
|
|
Apr 26
|
What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
|
|
Apr 18
|
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
|
|
Apr 8
|
Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year
|
|
Apr 3
|
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
|
|
Mar 22
|
Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
|
|
Mar 22
|
Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?
|
|
Mar 20
|
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
|
|
Mar 5
|
FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
|
|
Mar 4
|
J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer
|
|
Feb 14
|
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology
|
|
Feb 13
|
Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
|
|
Feb 12
|
Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma
|